Anirvan Ghosh - Nov 3, 2022 Form 4 Insider Report for Unity Biotechnology, Inc. (UBX)

Role
Chief Executive Officer, Director
Signature
/s/ Alexander Nguyen, Attorney-in-Fact for Anirvan Ghosh
Stock symbol
UBX
Transactions as of
Nov 3, 2022
Transactions value $
-$2,638
Form type
4
Date filed
11/4/2022, 04:49 PM
Previous filing
Sep 15, 2022
Next filing
Nov 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBX Common Stock, $0.0001 par value Sale -$2.64K -1.1K -1.12% $2.40 97.2K Nov 3, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
F2 Includes Restricted Stock Units which vest over time measured from the grant date.
F3 Reflects a 1-for-10 reverse stock split of the Issuer's common stock, effected by the Issuer on October 19, 2022, which was exempt from reporting pursuant to Rule 16a-9.